


Medy-Tox Revenue
Pharmaceutical Manufacturing • 10F Gimyoung BD 1694-10, Seocho 4-dong Seocho-gu, Korea, Republic of • 21-50 Employees
Medy-Tox revenue & valuation
| Annual revenue | $2,566,650 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $8,300,000 |
| Total funding | $57,800,000 |
Key Contacts at Medy-Tox
Kyungmin Han
Director
윤기영 Eeii
Director
Ki Young Yoon
Director
Company overview
| Headquarters | 10F Gimyoung BD 1694-10, Seocho 4-dong Seocho-gu, Seoul, 137-883, KR |
| Website | |
| NAICS | 3254 |
| Keywords | Development And Manufacture Of Botunlinum Toxin |
| Employees | 21-50 |
| Socials |
Medy-Tox Email Formats
Medy-Tox uses 2 email formats. The most common is {first name} (e.g., john@spo.go.kr), used 55.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@spo.go.kr | 55.6% |
{last name} | doe@spo.go.kr | 44.4% |
About Medy-Tox
Medy-Tox is a biopharmaceutical company that manufactures injectable botulinum toxin type A with the same quality to Allergan's Botox, but with more economical price of that. Medy-Tox is expanding its share in global market, and will increase its products in near future.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Medy-Tox has 4 employees across 2 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



